Profil has long-standing experience with clinical science in the field of diabetes. We combine the careful and critical diligence of independent academic science with top standards of industrial research. Profil contributes widely to scientific presentations and publications at international scientific meetings and in international peer-reviewed scientific journals.

• Performance of more than 150 in-house trials (> 130 phase I and II trials) in people with diabetes including more than 50 in people with type 1 diabetes
• Publication of more than 200 peer-reviewed scientific papers and reviews (cumulated impact factor > 400) and more than 300 abstracts at scientific conferences; more than 300 oral presentations at national and international meetings
• Profil scientists have been involved in scientific discussions with authorities, e.g. as consultants in FDA advisory board meetings or at EMEA scientific advice hearings
• Profil scientists are members of scientific advisory boards and academic study groups

Home